Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese (Q28477784)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese	scientific article

Statements

scholarly article

0 references

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Zhuofeng Lin

1

0 references

Zhihong Zhou

2

0 references

Yanlong Liu

3

0 references

Qi Gong

4

0 references

Xinxin Yan

5

0 references

Jian Xiao

6

0 references

Xiaojie Wang

7

0 references

Shaoqiang Lin

8

0 references

Wenke Feng

9

0 references

Xiaokun Li

10

0 references

language of work or name

0 references

publication date

15 April 2011

0 references

0 references

6

0 references

4

0 references

e18398

0 references

copyright license

Creative Commons Attribution 4.0 International

15 April 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Actions and mode of actions of FGF19 subfamily members

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

19 March 2017

Fibroblast growth factor 23: roles in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

19 March 2017

FGF-21 as a novel metabolic regulator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

19 March 2017

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

19 March 2017

Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

19 March 2017

Prevalence of chronic kidney disease in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

7 April 2017

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

7 April 2017

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

FGF21: a novel prospect for the treatment of metabolic diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

The FGF family: biology, pathophysiology and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Serum levels of the adipokine FGF21 depend on renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Fibroblast growth factor 21 corrects obesity in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Mini-review: endocrine actions of fibroblast growth factor 19.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Left ventricular hypertrophy in the renal patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Acidic fibroblast growth factor reduces rat skeletal muscle damage caused by ischemia and reperfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

The serum level and urinary excretion of beta2-microglobulin in health and renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

29 September 2017

Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

2 June 2018

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

2 June 2018

Chronic kidney disease predicts cardiovascular disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Dyslipidemia is associated with ventricular tachyarrhythmia in patients with acute ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018398

21 January 2018

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

27 November 2018

Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078122

27 November 2018

Acidic fibroblast growth factor reduces renal morphologic and functional indicators of injury caused by ischemia and reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of basic fibroblast growth factor on left ventricular geometry in rats subjected to coronary occlusion and reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: evidence for selective modulation of FGF-2-induced angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21525989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0018398

0 references

2011PLoSO...618398L

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28477784&oldid=1869393420"